Key tongue cancer companies driving the innovation and addressing the unmet needs in this therapeutic space include Modra Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb Company, Cipla Inc., Eli-Lilly, F. Hoffmann-La Roche, Fresenius Kabi AG, Intas Pharmaceuticals Ltd., MERCK & CO. INC., VIATRIS INC., Sanofi S.A, Teva Pharmaceuticals Industries Ltd, GSK, Novartis, Pfizer and Orca...